<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HD0602837AEDA49E591C5216C8A23CC7A" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 6545 IH: Protecting Americans from Unsafe Drugs Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-02-01</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 6545</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220201">February 1, 2022</action-date><action-desc><sponsor name-id="K000394">Mr. Kim of New Jersey</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.</official-title></form><legis-body id="H17D81FE0BCAB4056ADAEDAEF68EB39DA" style="OLC"><section id="HB40F1BB09DCB45768EA9E29933567895" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Protecting Americans from Unsafe Drugs Act of 2022</short-title></quote>.</text></section><section id="H71118E41D0414587A327EA16E194B86E" section-type="subsequent-section"><enum>2.</enum><header>Notification, nondistribution, and recall of drugs</header><subsection id="HA87316C1664647FE8650B0DACEFBE731"><enum>(a)</enum><header>Order To cease distribution and recall</header><text>Section 569D of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-8d">21 U.S.C. 360bbb–8d</external-xref>) is amended—</text><paragraph id="H433C248401984F74B8E1F117C4D0F544"><enum>(1)</enum><text>in the section heading, by striking <quote><header-in-text level="section" style="OLC">controlled substances</header-in-text></quote> and inserting <quote><header-in-text level="section" style="OLC">drugs</header-in-text></quote>;</text></paragraph><paragraph id="HEA7B7C7957394456B44A5420C1EDAC91"><enum>(2)</enum><text>by striking <quote>controlled substance</quote> each place such term appears and inserting <quote>drug</quote>;</text></paragraph><paragraph id="HD58F4BED4FE44841B69AC6FA38A22C0A"><enum>(3)</enum><text>in subsection (b)—</text><subparagraph id="H36F44A518B4944D1BC998792CB271BD3"><enum>(A)</enum><text>by striking <quote>controlled substances</quote> and inserting <quote>drugs</quote>; and</text></subparagraph><subparagraph id="HC4819D744BF54EFD9FF45BFF95BB4701"><enum>(B)</enum><text>by inserting <quote>of subsection (a)</quote> after <quote>an order pursuant to paragraph (1) or an amended order pursuant to subparagraph (B) or (C) of paragraph (3)</quote>; and</text></subparagraph></paragraph><paragraph id="H370396EC937E44758B3A8823092AEAE3"><enum>(4)</enum><text>in subsection (c), by striking <quote>or an official senior to such Director</quote> and inserting <quote>or the Director of the Center for Biologics Evaluation and Research (or an official senior to either such Director)</quote>.</text></paragraph></subsection><subsection id="HFF385B200BEF490B9A2E284C4DC3C9D8"><enum>(b)</enum><header>Imports and exports</header><text>Section 801(a) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/381">21 U.S.C. 381(a)</external-xref>) is amended by striking <quote>is a controlled substance subject to an order under section 569D</quote> and inserting <quote>is a drug subject to an order under section 569D</quote>.</text></subsection></section></legis-body></bill> 

